Fauske & Associates is pleased to announce that Michael Grolmes, Ph.D., a founding principal of FAI and owner of Centaurus Technology, is re-joining FAI's team as an exclusive consultant. Dr. Grolmes spent 10 years with FAI before founding Centaurus Technology where he has served as president for the last 20 years. Prior to working with FAI, Dr. Grolmes worked at Argonne National Laboratory.
BASF sells a majority stake in its coatings business to the investor Carlyle.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
